The immunogenicity and safety of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in Gambian infants

References

• Ward J, Co chi S. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: WB Saunders, 1988; 300–32.
   Google Scholar
• Ward JI, Lum MKW, Hall DB, Silimperi DR, Bender TR. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine trial. J Infect Dis 1986; 153: 17–26.
   PubMed Web of Science ®Google Scholar
• Hanna JN. The epidemiology of invasive Haemophilus influenzae infections in children under 5 years of age in the Northern Territory: a three-year study. Med J Aust 1990; 152: 234–40.
   PubMed Web of Science ®Google Scholar
• Bijlmer HA, van Alphen L, Greenwood BM, et al. The epidemiology of Haemophilus influenzae meningitis in children under 5 years of age in The Gambia, West Africa. J Infect Dis 1990; 161: 1210–15.
   PubMed Web of Science ®Google Scholar
• Bijlmer HA. World-wide epidemiology of Haemophilus influenzae meningitis; industrialized versus non-industrialized countries. Vaccine 1991; 9(suppl.):S5.
   PubMed Web of Science ®Google Scholar
• Funkhouser A, Steinhoff MC, Ward J. Haemophilus influenzae disease and immunization in developing countries. Rev Infect Dis 1991; 13(Suppl.6):S542–54.
   PubMedGoogle Scholar
• Greenwood BM. Epidemiology of acute lower respiratory tract infections, especially those due to Haemophilus influenzae type b, in The Gambia, West Africa. J Infect Dis 1992; 165(Suppl.l):S26–8.
   Google Scholar
• Cochi SL, Broome CV, Hightower AW. Immunization of US children with Haemophilus influenzae type b polysaccharide vaccine: a cost-effectiveness model of strategy assessment. JAMA 1985; 253: 521–9.
   PubMed Web of Science ®Google Scholar
• Campbell H, Byass P, Ahonkhai VI, Velia PP, Greenwood BM. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neis-seria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Pediatrics 1990; 86: 102–7.
   PubMed Web of Science ®Google Scholar
• Byass P, Hanlon PW, Hanlon LCS, Marsh VM, Greenwood BM. Microcomputer management of a vaccine trial. Comput Biol Med 1988; 18: 179–93.
   PubMed Web of Science ®Google Scholar
• Farr RS. A quantitative immunochemical measure of the primary interaction between I*BSA and antibody. J Infect Dis 1958; 103: 239–62.
   PubMed Web of Science ®Google Scholar
• Ward JI, Greenberg DP, Anderson PW, et al. Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. J Clin Microbiol 1988; 26: 72–8.
   PubMed Web of Science ®Google Scholar
• Claesson BA, Trollfors B, Lagergard T, et al. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18 to 23 month-old children. J Pediatr 1988; 112: 695–702.
   PubMed Web of Science ®Google Scholar
• Claesson BA, Schneerson R, Robbins JB, et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr 1989; 114: 97–100.
   PubMed Web of Science ®Google Scholar
• Watemberg N, Dagan R, Arbelli Y, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991; 10: 758–61.
   PubMed Web of Science ®Google Scholar
• Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunological response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoid-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991; 10: 764–71.
   PubMed Web of Science ®Google Scholar
• Kayhty H, Eskola J, Peltola H, et al. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child 1991; 145: 223–7.
   PubMedGoogle Scholar
• Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four Haemophilus influenzae type b vaccines. J Pediatr 1992; 120: 184–9.
   PubMed Web of Science ®Google Scholar
• Booy R, Taylor SA, Dobson S RM, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunization schedule. Arch Dis Child 1992; 67: 475–8.
   PubMed Web of Science ®Google Scholar
• Mulholland EK, Todd J, Rowe M, et al. Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine. Ann Trop Paediatr 1993; 13: 153–8.
   PubMed Web of Science ®Google Scholar
• Mulholland EK, Ahonkhai VI, Greenwood AM, et al. Safety and immunogenicity of Haemophilus influenzae type b-Neisseria meningitidis Group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-perrussis vaccine in young Gambian infants. Pediatr Infect Dis J 1993; 12: 632–7.
   PubMed Web of Science ®Google Scholar
• Claesson BA, Schneerson R, Lagergard T, et al. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatr Infect Dis J 1991; 10: 560–4.
   PubMed Web of Science ®Google Scholar
• Parke JC, Schneerson R, Reimer M, et al. Clinical and immunologic responses to Haemophilus influenzae type b tetanus toxoid conjugate vaccine in infants injected at 3, 5 7 and 18 months of age. J Pediatr 1991; 118: 184–90.
   PubMed Web of Science ®Google Scholar
• Fritzell B.ä Vaccin polyosidique contre Haemophilus influenzae b conjugué a la protéine tétanique. Immunol Med 1991; 8: 176–83.
   Google Scholar
• Granoff DM, Holmes SJ, Osterholm MT, et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993; 168: 663–71.
   PubMed Web of Science ®Google Scholar